. 2020 Jun;9(6):3794–3803. doi: 10.21037/tcr-19-2951

Table 3. Comparison of thyroid function measured by the Centaur^® XP immunoassay system between the nodular goitre patients and nodular goitre & papillary thyroid carcinoma patients.

Risk factor	NG (n=224)	NG&PTC (n=58)	P value
FT3	3.18±0.48	3.16±0.57	0.758
FT4	1.27±0.67	1.48±1.81	0.400
TSH	1.75±2.69	2.08±2.44	0.397

Table 3. Comparison of thyroid function measured by the Centaur® XP immunoassay system between the nodular goitre patients and nodular goitre & papillary thyroid carcinoma patients.